Tumor suppressor gene inactivation is a crucial event in oncogenesis. Gene
inactivation mechanisms include events resulting in loss of heterozygosity
(LOH), gene mutation, and transcriptional silencing. The contribution of ea
ch of these different pathways varies among tumor suppressor genes and by c
ancer type. The factors that influence the relative utilization of gene ina
ctivation pathways are poorly understood. In this study, we describe a deta
iled quantitative analysis of the three major gene inactivation mechanisms
for a model gene at two different genomic integration sites in mouse embryo
nic stem (ES) cells. In addition, we targeted the major DNA methyltransfera
se gene, Dnmt1, to investigate the relative contribution of DNA methylation
to these various competing gene inactivation pathways. Our data show that
gene loss is the predominant mode of inactivation of a herpes simplex virus
thymidine kinase neomycin phosphotransferase reporter gene (HSV TKNeo) at
the two integration sites tested and that this event is significantly reduc
ed in Dnmt1-deficient cells. Gene silencing by promoter methylation require
s Dnmt1, suggesting that the expression of Dnmt3a and Dnmt3b alone in ES ce
lls is insufficient to achieve effective gene silencing. We used a novel as
say to show that missense mutation rates are also substantially reduced in
Dnmt1-deficient cells. This is the first direct demonstration that DNA meth
ylation affects point mutation rates in mammalian cells. Surprisingly, the
fraction of CpG transition mutations was not reduced in Dnmt1-deficient cel
ls. Finally, we show that methyl group-deficient growth conditions do not c
ause an increase in missense mutation rates in Dnmt1-proficient cells, as p
redicted by methyltransferase-mediated mutagenesis models. We conclude that
Dnmt1 deficiency and the accompanying genomic DNA hypomethylation result i
n a reduction of three major pathways of gene inactivation in our model sys
tem.